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Urera aurantiaca is an Argentinean medicinal and edible species traditionally used to treat symptoms of inflammation. +e aim of
this study was to evaluate the anti-inflammatory activity of a methanol extract and its major compound. U. aurantiaca aerial parts
were extracted with methanol by maceration. A phytochemical analysis was performed, and the extract’s major component,
apigenin-7-glucuronide (A7G), was identified by spectroscopic and HPLC methods. +e analysis of the inflammatory mediators
nitric oxide (NO) and tumor necrosis factor alpha (TNF-α) in lipopolysaccharide- (LPS-) stimulated macrophages were used in the
evaluation of the extract and the major compound anti-inflammatory effects. +e extract reduced LPS-augmented NO release from
100 μg/mL (27%), reaching the highest inhibition at 1000 μg/mL (96.3%), while A7G reduced it 30.7% at 1 μg/mL, and its maximum
effect was 97.1% at 10 μg/mL. In the TNF-αmodel, the extract at 500 and 1000 μg/mL reduced LPS-augmented TNF-α by 13.5% and
93.9%, respectively; meanwhile, A7G reduced it by 26.2% and 83.8% at 5 and 10 μg/mL, respectively. U. aurantiaca popular use was
validated. In the present study, for the first time, A7G was isolated fromU. aurantiaca; furthermore, A7G showed anti-inflammatory
effect in the macrophage cell line RAW264.7 (ATCC) and seems to be responsible for the extract anti-inflammatory effect.
1. Introduction
Human body’s immune system reacts against injury gen-
erating inflammation. Injury can be caused by microbial
invasions, antigen entrance, or other cell damage. Inflam-
mation is part of a protective response searching for the
restoration of the normal balance. In this complex process,
endothelial cells, leucocytes, monocytes, and macrophages,
soluble mediators, and reactive oxygen species (ROS) are
involved. Although inflammation is a beneficial process, its
duration is extremely important. Unrestrained inflamma-
tion leads to a sustained pathological status. +us, chronic
inflammation is part of various diseases in which asthma,
atherosclerosis, cancers, chronic heart failure, diabetes
mellitus, metabolic syndrome-associated disorders, and
osteoporosis, among others, are included [1].
Macrophages have an important role in the generation
and development of the inflammation process through the
secretion of cytokines in response to a stimulus. Taking
advantage of this particular behavior, in this study, a
RAW264.7 (ATCC) macrophage cell line was used for the
evaluation of potential anti-inflammatory agents in two
inflammation models.
Urera aurantiaca Wedd. (Urticaceae) is an Argentinean
native plant that can also be found in Bolivia, Brazil, Par-
aguay, and Uruguay and is known with the common names
pica pica, pino guasú, ortiga, ortiga colorada, urtiga-branca,
and urtiguinha. +is herb is popularly used in the treatment
of rheumatic and tooth pain, for inflammation symptoms, in
case of varicose veins, furuncles, bruises, dermal diseases,
and trauma [2]. Its roots have been used for the preparation
of diuretic teas [3–5]. It is also used for hair loss, abdominal
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pain, and hemorrhoids [6]. Its leaves and fruits are edible,
and the leaves’ content in protein and minerals such as
calcium, magnesium, iron, and sulfur is remarkable [6, 7].
In previous works, U. aurantiaca in vivo anti-inflam-
matory and antinociceptive effects [8], its modulatory effect
on immune and tumoral cells during inflammation [9], and
its in vitro anti-inflammatory and antioxidant activities [10]
have been reported. However, U. aurantiaca chemical
composition is unknown.
+e aim of this study was to identify the main com-
ponent of the U. aurantiacamethanolic extract and evaluate
the anti-inflammatory effect of the extract and the com-
pound in LPS-activated macrophages.
2. Materials and Methods
2.1. Plant Material. Dr. R. H. Fortunato collected and
identified Urera aurantiaca Wedd. (Urticaceae) in March
2008 in Paraguay: Cerro Corá National Park, Naranjahai
(22°38′S; 58°36′W, 288m elevation, 2.5m altitude), Amambay
Department. A voucher specimen, number 9339, was de-
posited at Pharmacobotanical’s Museum, Pharmacy and
Biochemistry Faculty, Buenos Aires University, Argentina.
2.2. Preparation of the Plant Extract. Urera aurantiaca aerial
parts were dried and ground into a fine powder. It was
extracted by maceration with solvents in the crescent po-
larity order: methylene chloride, ethyl acetate, andmethanol.
+e methanol extract (UAP) was lyophilized. Its yield was
1.81%.
2.3. Isolation and Identification of the Extract’s Major
Compound. +e extract’s major compound was isolated by
preparative paper chromatography performed on Whatman
no. 3 using n-BuOH :AcOH :H2O (4 :1 :1) as solvents. A7G
was identified by UV and EIMS and confirmed by HPLC in
comparison with an external standard retention times and
UV spectra in three different HPLC systems, taking into
account literature data.
2.4. High-Performance Liquid Chromatography. +ree
HPLC methods were performed in order to identify the
extract’s major compound. A Varian 9000 instrument
equipped with a diode array detector and a Rheodyne in-
jector fitted with a 20 μl loop was used. A C18 column
(Agilent 5 μm, 150mm× 4.6mm) was employed for the
following three methods:
Method 1: mobile phase A: H2O/AcOH (98 : 2) and B:
MeOH/AcOH (98 : 2). Elution gradient: 15–40% B,
30min; 40–75% B, 10min; 75–85% B, 5min. Flow rate:
1.2mL/min. Detection: 325 nm [11].
Method 2: mobile phase A: H2O/formic acid (98 : 2)
and B: MeOH/formic acid (98 : 2). Elution gradient:
15–40% B, 15min; 40–75% B, 5min; 75–85% B, 5min;
85–100% B, 5min; 100% B, 5min. Flow rate: 0.8mL/
min. Detection: 325 nm.
Method 3: mobile phase A: 0.5% phosphoric acid in
water and solvent B: 0.5% phosphoric acid in aceto-
nitrile. Elution gradient: 8% B, 1min; 8–25% B, 19min;
25% B, 7min; 25–100% B, 3min; 100–8% B, 2min; 8%
B, 10min. Flow rate: 1.2mL/min. Detection: 330 nm.
2.5. Macrophage Culture Conditions. +e American Type
Culture Collection (ATCC) RAW264.7 murine macrophage
cell line was cultured in a colorless Dulbecco’s Modified
Eagle’s medium which was supplemented with 10% FBS,
2mM glutamine, 100 IU/mL penicillin, and 100 μg/mL
streptomycin. Cells were kept in a humidified incubator with
5% CO2 at 37°C.
2.6. Total Nitrite Determination. Total nitrite was measured
as an indicator of NO production. Macrophages were
incubated for 24 h in medium (basal conditions) or with
LPS (1 μg/mL) alone or in the presence of different con-
centrations of the extract or A7G. After incubation, all
supernatants were collected to determine the NO levels
and the cells were used to determine proliferation. +e
nitrite accumulated in the culture medium was determined
by the Griess reaction [12]: 100 μL of the supernatant was
mixed with 100 μL of Griess reagent (50 μL of 1% sulfa-
nilamide solution in 5% phosphoric acid and 50 μL of 0.1%
naphthylene diamine dihydrochloride solution). +e ab-
sorbance was read at 540 nm after 20min incubation. Serial
dilutions of a NaNO2 solution were used to build a
standard curve.
2.7. Cell Proliferation. Cell proliferation was determined by
the reduction in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT). After 24 h incubation and
separation of the supernatant, the cells were incubated for
4 h in 100 μL medium and 10 μl MTT (5mg/mL). +e
formazan formed was dissolved in acidified isopropanol
(0.04N HCl in isopropanol). +e absorbance was read at
540 nm.
2.8. TNF-α Determination. TNF-α was determined in the
supernatant of cultured macrophages using the commercial
Cayman Chemical kit TNF-α (mouse) ELISA kit in accor-
dance with the manufacturer’s recommendations. Macro-
phages were incubated for 24 h in medium (basal
conditions) or with LPS (1 μg/mL) alone or in the presence of
different concentrations of the extract or A7G. After in-
cubation, all supernatants were collected to determine the
TNF-α level.
2.9. Statistical Analysis. Data were expressed as the average
of triplicate values of three independent experiments.
Multiple comparisons were performed by analysis of vari-
ance (ANOVA) and Dunnett’s test. p< 0.05 was considered
statistically significant.
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3. Results and Discussion
Taking into account U. aurantiaca popular use, the aim of
this study was to evaluate a methanol extract anti-inflam-
matory activity and identify its active compounds. For this
purpose, a phytochemical analysis was performed. Two in
vitro inflammation models were used to assess the sample
activity.
First, the extract was analyzed and fractioned in order to
isolate and identify its major compound. A7G (0.0095mg/
mg extract) was obtained as a light-yellow powder. UV
(λmax, nm): MeOH: 268, 325; NaOMe: 272, 339, 391; AlCl3:
277 (sh), 300 (sh), 323 (sh), 358; AlCl3 +HCl: 277 (sh), 315,
358; NaOAc: 268, 283 (sh), 335 (sh), 393; NaOAc+HBO3:
269, 335 (sh), 397. EIMS (70 eV) m/z (% rel. int.): 269 [M-
Glu]+ (2.6), 176 [Glu-H]+ (73.1).+is is the first time A7G is
reported in U. aurantiaca. UV spectra and HPLC retention
times of the major peak and a standard were compared in
three different systems. A cochromatography was also
performed (data not shown). In Figure 1, the extract HPLC
profile obtained when method 1 was performed is shown.
A7G is derived from the flavones apigenin that is a
nontoxic and nonmutagenic flavonoid, present in fruits
and vegetables such as cardoon, celery, artichoke, parsley,
and others, some of which are widely marketed as dietary
and herbal supplements [13]. It is known that A7G presents
anti-inflammatory effect and is currently prescribed to treat
inflammatory diseases such as upper respiratory infections
[14, 15]. +is is the first time A7G is described in
U. aurantiaca.
LPS can be used as an external substance to generate
macrophage activation and consequent release of inflam-
matory mediators [16]. In response to an infectious chal-
lenge, bacterial components such as LPS induce monocyte
differentiation into classically activatedmacrophages, which,
once activated, are able to kill pathogens through phago-
cytosis, produce ROS, NO, enzymes, and inflammatory
cytokines such as TNF-α [17]. +e proinflammatory cyto-
kine TNF-α and the reactive free radical NO are inflam-
matory mediators secreted by macrophages. Macrophages
are involved not only in the inflammation progress but also
in the development of inflammatory diseases. In this study,
TNF-α and NO were evaluated using macrophages incu-
bated with LPS in presence of different concentrations of the
extract or A7G.
As expected, the treatment of RAW264.7 cells with LPS
increased NO levels (Figure 2). At basal conditions, neither
the extract nor the compoundmodified NO level. Under LPS
effect, the extract decreased NO production in all the doses
tested, in a concentration-dependent manner. +e extract
was able to reduce NO-augmented release by 27% from the
lowest dose, 100 μg/mL. +e maximum inhibitory effect was
96.3% at 1000 μg/mL. Moreover, the extract caused a
complete reversion of NO level, reaching basal levels at 500
and 1000 μg/mL, in agreement with what had been observed
before [10]. A7G also showed an anti-inflammatory effect
from the lowest dose, 1 μg/mL, representing 30.7% inhibi-
tion, and in a concentration-dependent manner. Further-
more, its maximum inhibitory effect was 97.1% inhibition
(10 μg/mL). A7G was also able to revert LPS effect (5 and
10 μg/mL). It is interesting to note that the A7G tested
concentrations are in the order in which A7G is present in
the extract, so the effect observed for the extract could be
related principally to A7G.
+e extract and A7G effect was also evaluated in the
TNF-α assay (Figure 3). Neither the extract nor the major
compound activity on TNF-α had been described before.
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Figure 1: A: Extract HPLC profile in system 1: major peak retention time (Rt): 31.12min (A7G standard, data not shown, Rt: 31.15min). B:
UAP major peak and A7G standard superposed UV spectra. C: A7G molecular structure.
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inflammation-related disorders by inducing different
pathways and signaling molecules such as NF-ĸB. NF-ĸB is a
transcription factor that regulates gene expression in the
setting of the inflammatory process. NF-ĸB plays an essential
beneficial role in normal physiology, but its inappropriate
regulation is implicated in the pathogenesis of several
diseases. At basal conditions, the extract and the compound
were capable of decreasing TNF-α level. Also, A7G and the
extract significantly decreased TNF-α level in a concentra-
tion-dependent manner in LPS-stimulated macrophages.
+e maximum inhibition effect was 93.9% for the extract
(1000 μg/mL) and 97.1% for A7G (10 μg/mL). +ese were
also the doses in which the LPS effect was completely
reverted, reaching basal levels. A7G seems to be responsible
for the effect exerted by the extract.
4. Conclusion
In this work, A7G, U. aurantiaca major compound, was
identified for the first time. A7G andU. aurantiacamethanol
extract activity upon inflammatory mediators such as NO
and TNF-α were evaluated. Both the flavonoid and the
extract prevented the inflammatory reaction induced by LPS
in RAW264.7 cells, decreasing TNF-α and nitrite release.
Urera aurantiaca popular use as an anti-inflammatory agent
was consequently validated. A7G seems to be responsible for






NF-ĸB: Nuclear factor ĸB
NO: Nitric oxide
ROS: Reactive oxygen species
TNF-
α:
Tumor necrosis factor alpha
UAP: Urera aurantiaca methanol extract.
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Supplementary Materials
Graphical summary of the in vitro anti-inflammatory ac-
tivity of Urera aurantiaca methanol extract and its main
compound, apigenin-7-glucuronide: the inflammatory me-
diators nitric oxide (NO) and tumor necrosis factor-alpha
(TNF-α) in lipopolysaccharide- (LPS-) stimulated macro-
phages were used in the evaluation of the extract and the






























































Figure 3: Effect of A7G and the extract (UAP) on TNF-α con-
centration. +e results are expressed as index TNF-α/MTT and
represent means (SEM of three experiments made in triplicate).
Basal: cells without treatment; LPS: cells previously treated with
LPS. +e statistical differences were determined by ANOVA fol-
lowed by Dunnett’s test (∗p< 0.05, ∗∗p< 0.01, and ∗∗∗p< 0.001:
statistically different respect to basal; #p< 0.05, ##p< 0.01, and



























































### ### ### ###
Figure 2: Effect of A7G and the extract (UAP) on nitrite release.
+e results are expressed as index NO/MTT and represent means
(SEM of three experiments made in triplicate). Basal: cells without
treatment; LPS: cells previously treated with LPS. +e statistical
differences were determined by ANOVA followed by Dunnett’s test
(∗∗∗p< 0.001, statistically different respect to basal; ###p< 0.001,
statistically different respect to LPS).
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show total nitrite levels and TNF-α level of untreated cells
and LPS- or LPS + extract-treated cells. Graphs in violet
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